Gt Biopharma Stock Forecast

Buy or Hold candidate since May 28, 2026 Gain 10.13%

The GT Biopharma, Inc. stock price fell by -4.57% on the last day (Monday, 22nd Jun 2026) from $0.514 to $0.491. During the last trading day the stock fluctuated 14.95% from a day low at $0.485 to a day high of $0.557. The price has been going up and down for this period, and there has been a 12.4% gain for the last 2 weeks. Volume has increased on the last day by 1 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $1.45 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $0.515 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 10.69% during the next 3 months and, with a 90% probability hold a price between $0.333 and $0.570 at the end of this 3-month period.

GTBP Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Thursday, June 18, 2026, and so far it has fallen -4.57%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). GT Biopharma, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The GT Biopharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.466 and $0.419. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for GT Biopharma, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.439 and $0.430. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, GT Biopharma, Inc. finds support just below today's level at $0.439. If this is broken, then the next support from accumulated volume will be at $0.430 and $0.394.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0725 between high and low, or 14.95%. For the last week, the stock has had daily average volatility of 11.32%.

Our recommended stop-loss: $0.468 (-4.58%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (GTBP) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect GT Biopharma, Inc. to open at $0.511, and during the day (based on 14 day Average True Range), to move between $0.466 and $0.515, which gives a possible trading interval of +/-$0.0481 (+/-10.31%) up or down from last closing price. If GT Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 10.31% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.514 (4.79%) than the support at $0.439 (10.52%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is GT Biopharma, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for GT Biopharma, Inc. stock to perform well in the short-term.

Current score: 2.131 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $0.511 ( 4.17%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk